Related Experiment Videos
Liver gene therapy: advances and hurdles
1Department of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Gene Therapy
|September 30, 2004
Summary
Liver gene therapy offers an alternative to transplantation for liver diseases. Challenges include immune response and cell proliferation, but successful gene transfer can correct genetic defects.
Area of Science:
- Hepatology
- Molecular Biology
- Immunology
Background:
- Orthotopic liver transplantation is the primary treatment for many liver diseases.
- The liver's unique characteristics support both in vivo and ex vivo gene transfer strategies.
- Gene therapy aims to provide an alternative to liver transplantation.
Purpose of the Study:
- To review liver diseases amenable to gene therapy.
- To discuss current vector technologies for liver gene transfer.
- To highlight advances and challenges in the field.
Main Methods:
- Review of in vivo and ex vivo gene transfer approaches.
- Analysis of vector technology and host immune responses.
- Evaluation of hepatocyte proliferation and liver repopulating abilities.
Main Results:
- In vivo gene transfer is less invasive but often limited by immune responses.
- Ex vivo gene transfer allows targeted delivery but faces challenges with hepatocyte proliferation.
- Successful gene transfer can lead to long-term correction of genetic liver defects under specific conditions.
Conclusions:
- Liver gene therapy holds promise for treating genetic liver diseases.
- Overcoming immune responses and improving cell engraftment are key challenges.
- Further advancements in vector technology and delivery methods are crucial for clinical success.